Innoviva (INVA) Change in Acquisitions & Divestments (2010 - 2020)
Innoviva (INVA) posted Change in Acquisitions & Divestments of $4.0 million for Q3 2020, down 85.71% on a QoQ basis from $28.0 million in Q2 2020, and down 96.12% year-over-year from $103.0 million in Q4 2019.
Innoviva (INVA) Change in Acquisitions & Divestments (2010 - 2020) Analysis & Trends
Innoviva's Change in Acquisitions & Divestments history runs 11 years deep, the most recent figure standing at $4.0 million for Q3 2020.
- Quarterly Change in Acquisitions & Divestments fell 96.12% year-over-year to $4.0 million in Q3 2020, while the trailing twelve-month figure through Jun 2021 was $4.0 million (down 98.32% YoY) and the FY2020 annual result came in at $86.0 million, down 59.8% from the prior year.
- Change in Acquisitions & Divestments was $4.0 million for Q3 2020 at Innoviva, down from $28.0 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $103.0 million in Q3 2019 and bottomed at -$44.4 million in Q4 2017.
- A 5-year average of $25.8 million and a median of $27.0 million in 2016 frame the typical range for Change in Acquisitions & Divestments.
- Annual changes were most pronounced in 2016 — Change in Acquisitions & Divestments plunged 172.48% — and 2019, when it jumped 1224.98%.
- Innoviva's Change in Acquisitions & Divestments stood at $85.4 million in 2016, then tumbled by 151.96% to -$44.4 million in 2017, then soared by 109.01% to $4.0 million in 2018, then soared by 1224.98% to $53.0 million in 2019, then sank by 92.45% to $4.0 million in 2020.
- Business Quant data shows INVA's Change in Acquisitions & Divestments at $4.0 million in Q3 2020, $28.0 million in Q2 2020, and $54.0 million in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 470.97 Bn | 466.18 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.05 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.42 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 1.00 Bn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 4.00 Mn |
| Sep 30, 2020 | 4.00 Mn |
| Jun 30, 2020 | 28.00 Mn |
| Jun 30, 2020 | 28.00 Mn |
| Mar 31, 2020 | 54.00 Mn |
| Mar 31, 2020 | 54.00 Mn |
| Dec 31, 2019 | 53.00 Mn |
| Dec 31, 2019 | 53.00 Mn |
| Sep 30, 2019 | 103.05 Mn |
| Sep 30, 2019 | 103.05 Mn |
| Jun 30, 2019 | 30.00 Mn |
| Jun 30, 2019 | 30.00 Mn |
| Mar 31, 2019 | 27.88 Mn |
| Mar 31, 2019 | 27.88 Mn |
| Dec 31, 2018 | 4.00 Mn |
| Dec 31, 2018 | 4.00 Mn |
| Sep 30, 2018 | 16.50 Mn |
| Sep 30, 2018 | 16.50 Mn |
| Jun 30, 2018 | 23.00 Mn |
| Jun 30, 2018 | 23.00 Mn |